n(g),n(g')-dimethyl-l-arginine has been researched along with Coronary Stenosis in 9 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Coronary Stenosis: Narrowing or constriction of a coronary artery.
Excerpt | Relevance | Reference |
---|---|---|
"Previous studies have shown that Asymmetric Dimethyl Arginine (ADMA) is increased significantly during coronary artery diseases (CAD)." | 7.88 | Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors. ( Ayati, N; Elyasi, S; Ghayour-Mobarhan, M; Mohammadpour, AH; Moohebati, M; Sahebkar, A, 2018) |
" A total of 83 patients with hypercholesterolemia and angiographically documented mild coronary artery stenosis were randomized to rosuvastatin treatment (20 mg) or atorvastatin treatment (40 mg) once daily for 6 weeks after a 4-week dietary lead-in phase." | 5.19 | Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease. ( Akturk, E; Altas, Y; Atas, H; Balta, S; Can, C; Demirkol, S; Erdem, K; Korkmaz, H; Kurtoglu, E; Sincer, I; Yilmaz, M, 2014) |
"Previous studies have shown that Asymmetric Dimethyl Arginine (ADMA) is increased significantly during coronary artery diseases (CAD)." | 3.88 | Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors. ( Ayati, N; Elyasi, S; Ghayour-Mobarhan, M; Mohammadpour, AH; Moohebati, M; Sahebkar, A, 2018) |
"It has been shown that asymmetric dimethylarginine (ADMA), an endogenous competitive antagonist of nitric oxide (NO) synthase, inhibits angiogenesis by reducing the production and bioavailability of NO." | 1.35 | [The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals]. ( Baysal, E; Duru, E; Maden, O; Saşmaz, A; Selçuk, H; Selçuk, MT; Temizhan, A; Ulupinar, H, 2008) |
"Asymmetric dimethylarginine (ADMA) that is an endogenous inhibitor of NO synthesis may impair the effective coronary collateral vessel development." | 1.35 | Asymmetric dimethylarginine and coronary collateral vessel development. ( Akyel, A; Biberoglu, G; Cengel, A; Hasanoglu, A; Kocaman, SA; Sahinarslan, A; Timurkaynak, T, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghayour-Mobarhan, M | 1 |
Ayati, N | 2 |
Sahebkar, A | 1 |
Moohebati, M | 1 |
Elyasi, S | 1 |
Mohammadpour, AH | 1 |
Kurtoglu, E | 1 |
Balta, S | 1 |
Sincer, I | 1 |
Altas, Y | 1 |
Atas, H | 1 |
Yilmaz, M | 1 |
Korkmaz, H | 1 |
Erdem, K | 1 |
Akturk, E | 1 |
Demirkol, S | 1 |
Can, C | 1 |
Mokhtari, Z | 1 |
Hosseini, S | 1 |
Miri, R | 1 |
Baghestani, AR | 1 |
Zahedirad, M | 1 |
Rismanchi, M | 1 |
Nasrollahzadeh, J | 1 |
Selçuk, MT | 1 |
Selçuk, H | 1 |
Temizhan, A | 1 |
Maden, O | 1 |
Ulupinar, H | 1 |
Baysal, E | 1 |
Duru, E | 1 |
Saşmaz, A | 1 |
Kocaman, SA | 1 |
Sahinarslan, A | 1 |
Biberoglu, G | 1 |
Hasanoglu, A | 1 |
Akyel, A | 1 |
Timurkaynak, T | 1 |
Cengel, A | 1 |
Celik, T | 2 |
Celik, M | 2 |
Iyisoy, A | 2 |
Işik, E | 1 |
Sun, T | 1 |
Huang, Y | 1 |
Phillips, MI | 1 |
Luo, X | 1 |
Zhu, J | 1 |
Shi, H | 1 |
Li, J | 1 |
Ari, H | 1 |
Ari, S | 1 |
Erdoğan, E | 1 |
Tiryakioğlu, O | 1 |
Ustündağ, Y | 1 |
Huysal, K | 1 |
Koca, V | 1 |
Bozat, T | 1 |
Yilmaz, MI | 1 |
Yuksel, UC | 1 |
Yaman, H | 1 |
1 trial available for n(g),n(g')-dimethyl-l-arginine and Coronary Stenosis
Article | Year |
---|---|
Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.
Topics: Arginine; Atorvastatin; Biomarkers; Coronary Angiography; Coronary Stenosis; Down-Regulation; Female | 2014 |
8 other studies available for n(g),n(g')-dimethyl-l-arginine and Coronary Stenosis
Article | Year |
---|---|
Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors.
Topics: Arginine; Biomarkers; Case-Control Studies; Coronary Artery Disease; Coronary Stenosis; Female; Huma | 2018 |
Relationship between Dietary Approaches to Stop Hypertension score and Alternative Healthy Eating Index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography.
Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Coronary Stenosis; Cross-Sectional Studies; | 2015 |
[The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
Topics: Arginine; Chromatography, High Pressure Liquid; Collateral Circulation; Confidence Intervals; Corona | 2008 |
Asymmetric dimethylarginine and coronary collateral vessel development.
Topics: Adult; Aged; Arginine; Biomarkers; Collateral Circulation; Coronary Angiography; Coronary Circulatio | 2008 |
[The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
Topics: Arginine; Collateral Circulation; Coronary Stenosis; Humans; Nitric Oxide Synthase | 2008 |
Growth differentiation factor 15 and coronary collateral formation.
Topics: Aged; Analysis of Variance; Arginine; Collateral Circulation; Coronary Angiography; Coronary Artery | 2010 |
A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Biomarkers; C-Reactive Protein; Coronary Angiography | 2010 |
The relationship between L-arginine/ADMA ratio and coronary collateral development in patients with low glomerular filtration rate.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Chi-Square Distribution; Collateral Circulatio | 2012 |